NovaSterilis

NovaSterilis uses supercritical CO2 solutions to promote safe, innovative products and improve lives.

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. At its core, NovaSterilis is a team of scientists, engineers, and business people committed to meeting our customers' needs through problem-solving. Our multi-disciplinary team of engineers, biochemists, and molecular and cellular biologists bring their broad and deep knowledge to every development challenge. We have the team, equipment, and processes readily available to provide scCO2 solutions that enable the implementation of manufacturing solutions that meet product safety requirements and performance and enable our partners to deliver safe, innovative products that advance patient healing and outcomes. With NovaSterilis you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

10/28/2026

This video shows sterilization conditions developing inside the chamber.

Achieving effective requires consistent pe*******on into complex geometries without compromising material integrity.

Understanding these process dynamics is critical when sterilizing sensitive materials and complex medical devices.

10/27/2026

Conventional cleaning can require extended washing cycles to remove residual processing agents.

offers an alternative approach to addressing cleaning efficiency and material compatibility.

Compare two-week washing protocols with scCO2-based processing: https://bit.ly/3Ssf6CA

10/26/2026

This week, we’re looking forward to attending MD&M Midwest to connect with industry leaders and explore how supercritical CO2 sterilization can help overcome complex compatibility challenges and advance next-generation medical products.

Will you be attending? Let’s connect and discuss how our innovative solutions can support your product development goals.

10/21/2026

Conventional relies on harsh chemicals that compromise tissue structure and mechanics.

Alternative approaches must remove immunogenic material without degrading scaffold performance.

This study explores a combined protocol that achieves substantial DNA reduction while preserving integrity. https://bit.ly/4qllAOP

10/20/2026

Elastomeric materials can experience dimensional distortion during sterilization, affecting device performance.

This purge versus no-purge comparison demonstrates how process conditions influence material stability.

Discover strategies to manage distortion while maintaining sterilization efficacy: https://bit.ly/3Vvea1L

10/19/2026

Sterilization compatibility is essential to protecting product integrity, safety, and performance throughout the sterilization process.

Because sterilization compatibility varies, evaluating material stability, product integrity, and functional performance early helps identify potential challenges before process validation.

Material Compatibility: https://bit.ly/3pueZIn
Therapeutics Compatibility: https://bit.ly/45HI7ux
Medical Device Compatibility: https://bit.ly/3S6SKnf

10/15/2026

We’re heading to MD&M Midwest!

As medical products become more advanced, traditional methods don’t always meet the demands of sensitive materials, biologics, and complex devices.

NovaSterilis is helping innovators overcome these challenges with , a low-temperature approach designed to expand what’s possible in sterilization.

If you’ll be at MD&M Midwest, connect with our team to discuss your sterilization and compatibility needs.

10/12/2026

Elastomer performance can shift during , affecting dimensions and mechanical properties.

provides a low-temperature approach when material integrity is critical.

Learn how controlled purging can further reduce expansion or distortion during :

Learn how sterilization can affect elastomeric materials, and how scCO₂ and Purge help manage material integrity and process control.

10/08/2026

Biomaterials that contain can be extremely sensitive to traditional procedures.

This study shows being used for the terminal sterilization of sensitive biomaterials because of its low temperature and low amounts of additives. Read more: https://bit.ly/40lwb0G

10/07/2026

This video shows water incorporation into CO2 over time.

Supercritical CO2 sterilization conditions can be tuned to preserve or adjust the hydration attributes of materials being processed.

To see how scCO2 interacts with water, watch this video.

Address

3109 North Triphammer Terrace
Lansing, NY
14882

Website

https://www.novasterilis.com/

Alerts

Be the first to know and let us send you an email when NovaSterilis posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.